Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Vit D3 for Early Symptoms of COVID-19

  • Read more about Vit D3 for Early Symptoms of COVID-19

Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination

  • Read more about Influences of Allergic Rhinitis and Allergen Immunotherapy on SARS-CoV-2 Vaccination

COvid iMaging With POSitron Emission Tomography

  • Read more about COvid iMaging With POSitron Emission Tomography

COVID-19 SARS-CoV-2 Antibody Testing Study

  • Read more about COVID-19 SARS-CoV-2 Antibody Testing Study

Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities

  • Read more about Evolution of Protective Immunization Against COVID-19 Among Hospital Workers in Health Care Facilities

Covid-19 Antibody Responses in Cystic Fibrosis

  • Read more about Covid-19 Antibody Responses in Cystic Fibrosis

Short-term Effect of COVID-19 Vaccine on Blood Pressure

  • Read more about Short-term Effect of COVID-19 Vaccine on Blood Pressure

Effect of COVID-19 Vaccine on Blood Pressure

  • Read more about Effect of COVID-19 Vaccine on Blood Pressure

Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19

  • Read more about Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19

Impact of the COVID-19 Pandemic on the Organization of Healthcare in France

  • Read more about Impact of the COVID-19 Pandemic on the Organization of Healthcare in France

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Current page 213
  • Page 214
  • Page 215
  • Page 216
  • Page 217
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA